Logo
  • Home
  • AI Agent
  • Annotations
  • Watchlists
  • Files
  • Pricing and plans
  • BlogAboutContact us
    APIMCP
    Terms of servicePrivacy policy

  • Get the full experience

    We save the real magic for signed-in users.

Logo
RARE US​

Ultragenyx Pharmaceutical Inc.(RARE US)

$15.65-0.301.88%Ext:$15.41-0.241.56%(Market Closed · 23:56:08 UTC)

Overview

ProfileEntity Structure

Documents

SEC Filings
CategorizedChronologicalBy Owner

Financials & Metrics

FinancialsChartingShort InterestEmployees

SEC Filings

Financials(52)

Expand
  • 10-QQ2ended 30 Jun 20264 Aug
  • 10-QQ1ended 31 Mar 20265 May
  • 10-KFY 2025ended 31 Dec 202518 Feb
  • 10-QQ3ended 30 Sept 20254 Nov 2025
  • 10-QQ2ended 30 Jun 20256 Aug 2025
  • 10-QQ1ended 31 Mar 20257 May 2025
  • 10-KFY 2024ended 31 Dec 202419 Feb 2025
  • 10-QQ3ended 30 Sept 20246 Nov 2024
  • 10-QQ2ended 30 Jun 20242 Aug 2024
  • 10-QQ1ended 31 Mar 20243 May 2024
  • 10-KFY 2023ended 31 Dec 202321 Feb 2024
  • 10-QQ3ended 30 Sept 20233 Nov 2023
  • 10-QQ2ended 30 Jun 20234 Aug 2023
  • 10-QQ1ended 31 Mar 20235 May 2023
  • 10-KFY 2022ended 31 Dec 202217 Feb 2023

Events(210)

Expand
  • 8-KOther Events19 Oct
  • 8-KEntry into a Material Definitive Agreement14 Oct
  • 8-KEntry into a Material Definitive Agreement7 Oct
  • 8-KOther Events17 Sep
  • 8-KOther Events2 Sep
  • 8-KOther Events19 Aug
  • 8-KOther Events11 Aug
  • 8-KResults of Operations and Financial Condition4 Aug
  • 8-KDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers18 May
  • 8-KResults of Operations and Financial Condition5 May
  • 8-KOther Events2 Apr
  • 8-KOther Events30 Mar
  • 8-KOther Events12 Mar
  • 8-KOther Events23 Feb
  • 8-KResults of Operations and Financial Condition12 Feb

Insider Ownership(627)

Expand
  • 4Statement of changes in beneficial ownership19 Oct
  • 4Statement of changes in beneficial ownership15 Sep
  • 4Statement of changes in beneficial ownership8 Sep
  • 4Statement of changes in beneficial ownership4 Aug
  • 4Statement of changes in beneficial ownership4 Aug
  • 4Statement of changes in beneficial ownership6 Jul
  • 4Statement of changes in beneficial ownership15 Jun
  • 4Statement of changes in beneficial ownership15 Jun
  • 4Statement of changes in beneficial ownership1 Jun
  • 4Statement of changes in beneficial ownership18 May
  • 4Statement of changes in beneficial ownership18 May
  • 4Statement of changes in beneficial ownership18 May
  • 4Statement of changes in beneficial ownership18 May
  • 4Statement of changes in beneficial ownership18 May
  • 4Statement of changes in beneficial ownership18 May

Beneficial Ownership(101)

Expand
  • SC 13GUltragenyx Pharmaceutical Inc.20 Oct
  • SC 13GUltragenyx Pharmaceutical Inc.14 Aug
  • SC 13GUltragenyx Pharmaceutical Inc.13 Aug
  • SC 13GUltragenyx Pharmaceutical Inc.7 Aug
  • SC 13G/AUltragenyx Pharmaceutical Inc.31 Jul
  • SC 13GUltragenyx Pharmaceutical Inc.31 Jul
  • SC 13G/AUltragenyx Pharmaceutical Inc.30 Jul
  • SC 13GUltragenyx Pharmaceutical Inc.12 May
  • SC 13GUltragenyx Pharmaceutical Inc.29 Apr
  • SC 13G/AUltragenyx Pharmaceutical Inc.27 Mar
  • SC 13G/AUltragenyx Pharmaceutical Inc.5 Feb
  • SC 13GUltragenyx Pharmaceutical Inc.5 Nov 2025
  • SC 13G/AUltragenyx Pharmaceutical Inc.24 Apr 2025
  • SC 13G/AUltragenyx Pharmaceutical Inc.12 Feb 2025
  • SC 13G/AUltragenyx Pharmaceutical Inc.10 Feb 2025

Other Ownership(39)

Expand
  • 144Huizenga Theodore Alan15 Sep
  • 144Horn Howard3 Aug
  • 144Horn Howard1 Jul
  • 144Parschauer Karah Herdman15 Jun
  • 144Sanders Corazon (Corsee) D.15 Jun
  • 144Horn Howard1 Jun
  • 144SULIMAN SHEHNAAZ18 May
  • 144Horn Howard1 May
  • 144Horn Howard1 Apr
  • 144Parschauer Karah Herdman10 Mar
  • 144Parschauer Karah Herdman6 Mar
  • 144Horn Howard3 Mar
  • 144Horn Howard2 Mar
  • 144Horn Howard2 Feb
  • 144Horn Howard2 Jan

Proxies(30)

Expand
  • DEFA14ADefinitive additional materials30 Apr
  • ARSANNUAL REPORT TO SECURITY HOLDERS27 Mar
  • DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS27 Mar
  • DEF 14ADEFINITIVE PROXY STATEMENT27 Mar
  • DEF 14ADEFINITIVE PROXY STATEMENT28 Mar 2025
  • DEFA14ADEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS28 Mar 2025
  • ARSANNUAL REPORT TO SECURITY HOLDERS28 Mar 2025
  • ARSAnnual report to security holders26 Apr 2024
  • DEFA14ADefinitive additional materials26 Apr 2024
  • DEF 14ADefinitive proxy statement26 Apr 2024
  • DEFA14ADefinitive additional materials24 Apr 2023
  • DEF 14ADefinitive proxy statement24 Apr 2023
  • DEFA14ADefinitive additional materials28 Apr 2022
  • DEF 14ADefinitive proxy statement28 Apr 2022
  • DEF 14ADefinitive proxy statement29 Apr 2021

Registrations(51)

Expand
  • S-8Registration statement (employee benefit plan)12 Jun
  • S-8Registration statement (employee benefit plan)18 Jul 2025
  • S-8Registration statement (employee benefit plan)12 Jul 2024
  • 424B5Prospectus filing (Rule 424(b)(5))14 Jun 2024
  • 424B5Prospectus filing (Rule 424(b)(5))12 Jun 2024
  • S-3ASRAutomatic shelf registration statement (S-3)21 Feb 2024
  • 424B5Prospectus filing (Rule 424(b)(5))20 Oct 2023
  • FWPFree writing prospectus19 Oct 2023
  • 424B5Prospectus filing (Rule 424(b)(5))17 Oct 2023
  • S-8Registration statement (employee benefit plan)8 Jun 2023
  • S-8Registration statement (employee benefit plan)17 Feb 2023
  • S-8Registration statement (employee benefit plan)15 Feb 2022
  • 424B5Prospectus filing (Rule 424(b)(5))7 May 2021
  • S-8Registration statement (employee benefit plan)12 Feb 2021
  • S-3ASRAutomatic shelf registration statement (S-3)12 Feb 2021

Filing Review Correspondence(1)

Expand
  • CORRESPFiling review correspondence17 May 2024

SEC Orders And Notices(8)

Expand
  • CT ORDERConfidential treatment order30 Aug 2018
  • CT ORDERConfidential treatment order20 Apr 2018
  • CT ORDERConfidential treatment order13 Jan 2017
  • CT ORDERConfidential treatment order9 Jan 2017
  • CT ORDERConfidential treatment order22 Dec 2015
  • EFFECTNotice of effectiveness8 Jul 2014
  • CT ORDERConfidential treatment order3 Feb 2014
  • EFFECTNotice of effectiveness30 Jan 2014

Tender Offers And Going Private(12)

Expand
  • SC TO-T/ATender offer statement (third-party, amendment)7 Nov 2017
  • SC TO-T/ATender offer statement (third-party, amendment)26 Oct 2017
  • SC TO-T/ATender offer statement (third-party, amendment)23 Oct 2017
  • SC TO-T/ATender offer statement (third-party, amendment)17 Oct 2017
  • SC TO-T/ATender offer statement (third-party, amendment)12 Oct 2017
  • SC TO-T/ATender offer statement (third-party, amendment)11 Oct 2017
  • SC TO-TTender offer statement (third-party)10 Oct 2017
  • SC TO-C8-K3 Oct 2017
  • SC TO-CFORM 8-K2 Oct 2017
  • SC TO-CFORM 8-K25 Sep 2017
  • SC TO-C8-K19 Sep 2017
  • SC TO-CFORM 8-K18 Sep 2017

Exempt Offerings(4)

Expand
  • DNotice of exempt offering of securities (Reg D)31 Dec 2012
  • DNotice of exempt offering of securities (Reg D)30 Jul 2012
  • DNotice of exempt offering of securities (Reg D)23 Jun 2011
  • DNotice of exempt offering of securities (Reg D)16 Mar 2011

Other(3)

Expand
  • SEC STAFF LETTERSEC STAFF LETTER2 Dec 2019
  • SEC STAFF LETTERSEC STAFF LETTER6 Nov 2019
  • CERTNASAUTO-GENERATED PAPER DOCUMENT29 Jan 2014